Endo International Bullish News | Upside PotentialEndo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first authorized generic versions of Mallinckrodt's Amitiza® (lubiprostone) 8 mcg and 24 mcg capsules.
According to IQVIA™, Amitiza® capsule sales were approximately $427 million for the 12 months ended September 30, 2020. (Source: prnewswire.com)
Endo International plc (NASDAQ: ENDP) announced that its subsidiary Endo Ventures Limited has entered into definitive agreements with Radius Health, Inc. (NASDAQ: RDUS) to register, commercialize and distribute abaloparatide on an exclusive basis in Canada. (Source: newswire.ca)
"We are very pleased to work with Radius to possibly bring a new treatment option to the market for Canadian osteoporosis patients," said Livio Di Francesco, Vice President and General Manager of Paladin.
Please leave me a message if you want to test the buy and sell indicators that i am using.
PAR
Beware of little expenses. A small leak will sink a great ship..Prediction: Naut is continually revisiting oversold status, and has been in a significant downtrend for two weeks. With no real progress or relevant updates, and the recent attempts initiate a pump cycle being met with crickets, expect a revisit to the range of the previous bottom at around 0.0003, with a possibility of going lower, but a high probability that insiders & large holders will be defending the 0.0003 level and will be accumulating at this price for a pump after Oct 1.
A double bottom could signal a reversal into bull market conditions coming into the first week of October, but be warned that an overexuberant bull market that pushes the price too quickly will likely run out of steam before reaching previous highs, so set your stops during the down and up cycles, and stagger your bids and offers at or around previous support levels.
Good luck.
